Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1976 Oct 1;144(4):946–959. doi: 10.1084/jem.144.4.946

Suppression by autogenous complementary idiotypes: the priority of the first response

PMCID: PMC2190429  PMID: 62017

Abstract

Complementary idiotypes or antibodies are considered to have combining site structures which are at least partly directed against each other. Complementary antibodies were induced in A/He mice by immunization with phosphorylcholine (PC)-containing antigens and by immunization with the PC-binding IgA myeloma protein TEPC-15 (T15). Both responses were monitored by enumerating plaque-forming cells (PFC) and assaying serum antibody levels against the corresponding antigens. Mice immunized at least three times with T15 in adjuvants had markedly suppressed responses to subsequent immunization with PC; similarly, mice preimmunized multiple times with PC had suppressed responses to immunizations with T15. In contrast, mice immunized with T15 in the interval between "primary" and "secondary" immunizations with PC had undiminished PFC responses to both antigens but significantly decreased antibody titers to PC. Simultaneous responses were also induced by immunizations with T15 superimposed on weekly immunizations with PC; with this regime, immunization with T15 actually enhanced the PFC response to PC, but serum antibody to PC was significantly lower than for mice immunized with PC only. Levels of serum antibody to PC were probably lower, either because anti-PC antibody was complexed with the complementary antibody directed against T15, or because the antibody directed against T15 prevented synthesis and/or release of anti-PC antibody by cells in vivo. Thus, an established prior autogenous immune response can dramatically suppress a subsequent primary complementary response, but the effects of complementary responses on each other are more complex with different sequences of immunization. Also, the effects of variables such as the amounts and ratios of the classes of antibodies on regulation of complementary responses remain to be defined.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown P. B., Köhler H., Rowley D. A. Specific suppression of the antibody response in vitro by serum from paralyzed mice. J Immunol. 1975 Aug;115(2):419–424. [PubMed] [Google Scholar]
  2. Claflin J. L., Davie J. M. Clonal nature of the immune response to phosphorylcholine (PC). V. Cross-idiotypic specificity among heavy chains of murine anti-PC antibodies and PC-binding myeloma proteins. J Exp Med. 1975 May 1;141(5):1073–1083. doi: 10.1084/jem.141.5.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Claflin J. L., Davie J. M. Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies. J Exp Med. 1974 Sep 1;140(3):673–686. doi: 10.1084/jem.140.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Claflin J. L., Davie J. M. Specific isolation and characterization of antibody directed to binding site antigenic determinants. J Immunol. 1975 Jan;114(1 Pt 1):70–75. [PubMed] [Google Scholar]
  5. Claflin J. L., Lieberman R., Davie J. M. Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells. J Exp Med. 1974 Jan 1;139(1):58–73. doi: 10.1084/jem.139.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Claflin J. L., Lieberman R., Davie J. M. Clonal nature of the immune response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of anti-phosphorylcholine antibodies. J Immunol. 1974 May;112(5):1747–1756. [PubMed] [Google Scholar]
  7. Cosenza H., Köhler H. Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science. 1972 Jun 2;176(4038):1027–1029. doi: 10.1126/science.176.4038.1027. [DOI] [PubMed] [Google Scholar]
  8. Cosenza H., Köhler H. Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2701–2705. doi: 10.1073/pnas.69.9.2701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eichmann K. Idiotype suppression. I. Influence of the dose and of the effector functions of anti-idiotypic antibody on the production of an idiotype. Eur J Immunol. 1974 Apr;4(4):296–302. doi: 10.1002/eji.1830040413. [DOI] [PubMed] [Google Scholar]
  10. Gearhart P. J., Sigal N. H., Klinman N. R. Heterogeneity of the BALB/c antiphosphorylcholine antibody response at the precursor cell level. J Exp Med. 1975 Jan 1;141(1):56–71. doi: 10.1084/jem.141.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hart D. A., Wang A. L., Pawlak L. L., Nisonoff A. Suppression of idiotypic specificities in adult mice by administration of antiidiotypic antibody. J Exp Med. 1972 Jun 1;135(6):1293–1300. doi: 10.1084/jem.135.6.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  13. Julius M. H., Herzenberg L. A. Isolation of antigen-binding cells from unprimed mice: demonstration of antibody-forming cell precursor activity and correlation between precursor and secreted antibody avidities. J Exp Med. 1974 Oct 1;140(4):904–920. doi: 10.1084/jem.140.4.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kappler J. W., van der Hoven A., Dharmarajan U., Hoffmann M. Regulation of the immune response. IV. Antibody-mediated suppression of the immune response to haptens and heterologous erythrocyte antigens in vitro. J Immunol. 1973 Oct;111(4):1228–1235. [PubMed] [Google Scholar]
  15. Kluskens L., Köhler H. Regulation of immune response by autogenous antibody against receptor. Proc Natl Acad Sci U S A. 1974 Dec;71(12):5083–5087. doi: 10.1073/pnas.71.12.5083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Köhler H. The response to phosphorylcholine: dissecting an immune response. Transplant Rev. 1975;27:24–56. [PubMed] [Google Scholar]
  17. Lieberman R., Potter M., Mushinski E. B., Humphrey W., Jr, Rudikoff S. Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med. 1974 Apr 1;139(4):983–1001. doi: 10.1084/jem.139.4.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McKearn T. J., Stuart F. P., Fitch F. W. Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens. J Immunol. 1974 Dec;113(6):1876–1882. [PubMed] [Google Scholar]
  19. Nisonoff A., Bangasser S. A. Immunological suppression of idiotypic specificities. Transplant Rev. 1975;27:100–134. doi: 10.1111/j.1600-065x.1975.tb00186.x. [DOI] [PubMed] [Google Scholar]
  20. Peaker P. J., Cicurei L., Nisonoff A. Enhancement of immunogenicity of a BALB-c myeloma protein in BALB-c mice. J Immunol. 1974 Sep;113(3):791–797. [PubMed] [Google Scholar]
  21. Potter M. Antigen-binding myeloma proteins in mice. Ann N Y Acad Sci. 1971 Dec 31;190:306–321. doi: 10.1111/j.1749-6632.1971.tb13543.x. [DOI] [PubMed] [Google Scholar]
  22. Rodkey L. S. Studies of idiotypic antibodies. Production and characterization of autoantiidiotypic antisera. J Exp Med. 1974 Mar 1;139(3):712–720. doi: 10.1084/jem.139.3.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rowley D. A., Fitch F. W., Stuart F. P., Köhler H., Cosenza H. Specific suppression of immune responses. Science. 1973 Sep 21;181(4105):1133–1141. doi: 10.1126/science.181.4105.1133. [DOI] [PubMed] [Google Scholar]
  24. Silver D. M., Winn H. J. Use of normal mouse serum to detect indirect plaque-forming cells. J Immunol. 1973 Oct;111(4):1281–1284. [PubMed] [Google Scholar]
  25. Spring S. B., Schroeder K. W., Nisonoff A. Quantitative investigations of idiotypic antibodies. V. Factors affecting the persistence and replacement of clones of antibody-producing cells. J Exp Med. 1971 Sep 1;134(3 Pt 1):765–785. doi: 10.1084/jem.134.3.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Strayer D. S., Cosenza H., Lee W. M., Rowley D. A., Köhler H. Neonatal tolerance induced by antibody against antigen-specific receptor. Science. 1974 Nov 15;186(4164):640–643. doi: 10.1126/science.186.4164.640. [DOI] [PubMed] [Google Scholar]
  27. Trenkner E., Riblet R. Induction of antiphosphorylcholine antibody formation by anti-idiotypic antibodies. J Exp Med. 1975 Nov 1;142(5):1121–1132. doi: 10.1084/jem.142.5.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Warner N. L. Membrane immunoglobulins and antigen receptors on B and T lymphocytes. Adv Immunol. 1974;19(0):67–216. doi: 10.1016/s0065-2776(08)60252-7. [DOI] [PubMed] [Google Scholar]
  29. Wason W. M., Fitch F. W. Suppression of the antibody response to SRBC with F(ab') 2 and IgG in vitro. J Immunol. 1973 May;110(5):1427–1429. [PubMed] [Google Scholar]
  30. Wernet P., Feizi T., Kunkel H. G. Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays. J Exp Med. 1972 Sep 1;136(3):650–655. doi: 10.1084/jem.136.3.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wigzell H., Mäkelä O. Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med. 1970 Jul 1;132(1):110–126. doi: 10.1084/jem.132.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES